Phase 2 Palliative Care Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Lysergic Acid Diethylamide (LSD) in Palliative Care
PainQuality of LifePsychological Distress+7 more
University Hospital, Basel, Switzerland60 enrolled4 locationsNCT05883540
Recruiting
Phase 1Phase 2
Pilot Study of MC in Paediatric Palliative Care
Palliative Care
Murdoch Childrens Research Institute10 enrolled1 locationNCT05615389
Recruiting
Phase 2
Administration of Intranasal Midazolam for Anxiety in Palliative Care
AnxietyPalliative CareAcute Anxiety
Insel Gruppe AG, University Hospital Bern36 enrolled5 locationsNCT06330584
Recruiting
Phase 2
Improvement of Quality of Life by Cannabinoids in Oncologic Patients
Quality of LifePalliative CareMedical Oncology+1 more
University Hospital Schleswig-Holstein170 enrolled4 locationsNCT06097533
Recruiting
Phase 2
A phase I/II double-blind, randomised controlled trial assessing effect of medicinal cannabis on quality of life and symptom control in advanced cancer.
Advanced CancerPalliative Care
Olivia Newton-John Cancer Research Institute119 enrolled4 locationsACTRN12619001534178
Completed
Phase 2
Intra-nasal fentanyl for breathlessness
Breathlessness in palliative care patients who have terminal illness from a non-malignant disease
Medical Director, Dr Ian Gwynne Robson20 enrolled2 locationsACTRN12617001399381
Recruiting
Phase 2
A pilot study to explore the safety of pyridostigmine in constipated palliative care patients
ConstipationPalliative Care
Calvary Mater Newcastle10 enrolled2 locationsACTRN12614000540617